60 minutes
Decentralized Clinical Trials have been gaining steam over the last decade, but it was the COVID-19 pandemic that cast its advantages into the limelight. Sponsors benefit by creating efficiencies virtually throughout drug discovery, research, and treatment phases. However, the greatest long-term benefactors will ultimately be the patients. Advancements in data analytics, diagnostic imaging, and genomics will enhance recruitment efforts. In turn, a diversity of candidates will enrich the data to reflect a more accurate depiction of disease states, treatment efficacy, and quality outcomes. This panel will discuss their how Digital Health has and will continue to change clinical trials.
